Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Materials (Basel, Switzerland)|November 26, 2022
Effects of Solution Treatment on Damping Capacities of Binary Mg-X (X = Ga and Er) AlloysXiaoyang Dong, Jinxing Wang, Zichuan Wang, et al.European Neurology|November 1, 2020
Predictive Value and Correlation of Neuron-Specific Enolase for Prognosis in Patients with Coma: A Systematic Review and Meta-AnalysisWen Ye, Yunliang Tang, Xiaoyang Dong, et al.Mediators of Inflammation|June 20, 2025
S100A11 Promotes Acute Pancreatitis by Upregulating Acinar Cell FerroptosisHuiyun Zhu, Hongxin Sun, Xianzhu Zhou, et al.Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituentJeffrey K Kerns, Hong Nie, William Bondinell, et al.Journal of Medicinal Chemistry|October 14, 2009
Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagoguesRobert W Marquis, Amparo M Lago, James F Callahan, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitorPatricia L Podolin, Brian J Bolognese, Donald C Carpenter, et al.Journal of Medicinal Chemistry|February 9, 2016
DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase InhibitorsPhilip A Harris, Bryan W King, Deepak Bandyopadhyay, et al.Journal of Medicinal Chemistry|July 3, 2019
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory DiseasesPamela A Haile, Linda N Casillas, Bartholomew J Votta, et al.ACS Medicinal Chemistry Letters|June 20, 2020
Correction to Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelPamela A Haile, Linda N Casillas, Michael J Bury, et al.ACS Medicinal Chemistry Letters|October 23, 2018
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelPamela A Haile, Linda N Casillas, Michael J Bury, et al.Pageof 5